Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
10 mai 2021 07h00 HE
|
Constellation Pharmaceuticals , Inc.
Dosing underway in the Phase 3 MANIFEST-2 clinical trialRecommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohortsUpcoming data presentation at ASCO...
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
24 févr. 2021 07h00 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...